A Comparative Analysis of Efficacy of Rituximab in Patients with Primary Membranous Nephropathy

被引：0
|
作者：
Zhang Qianwei [1 ]
Xie Liyi [1 ]
机构：
[1] Xi An Jiao Tong Univ, Affiliated Hosp 1, Xian, Shaanxi, Peoples R China
来源：
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY | 2024年 / 35卷 / 10期
关键词：
D O I：
10.1681/ASN.2024g2wf30dz
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
TH-PO591
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Rituximab in patients with membranous nephropathy and kidney insufficiency
    Guo, Yanhong
    Wang, Liuwei
    Wang, Yulin
    Li, Xiaodan
    Zhai, Zihan
    Yu, Lu
    Liang, Yan
    Liu, Peipei
    Tang, Lin
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [22] Comparations of efficacy and safety of rituximab, calcineurin inhibitors and cyclophosphamide in primary membranous nephropathy: a single-center retrospective analysis
    Luying Lu
    Shasha Cai
    Huayan Zhu
    Guangjun Liu
    Yaomin Wang
    Pingping Ren
    Lan Lan
    Xiaoqi Shen
    Liangliang Chen
    Ying Xu
    Jun Cheng
    Xiayu Li
    Jianghua Chen
    Fei Han
    BMC Nephrology, 25 (1)
  • [23] Optimization of rituximab therapy in primary membranous nephropathy with artificial intelligence
    Destere, A.
    Teyssiere, M.
    Merino, D.
    Cremoni, M.
    Benito, S.
    Gerard, A.
    Drici, M. D.
    Seitz-Polski, B.
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2023, 37 : 74 - 75
  • [24] Obinutuzumab versus rituximab for the treatment of refractory primary membranous nephropathy
    Xu, Mingyue
    Wang, Yifeng
    Wu, Meihe
    Chen, Ruiying
    Zhao, Wenqian
    Li, Mingxin
    Hao, Chuan-Ming
    Xie, Qionghong
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2024,
  • [25] Efficacy and safety of rituximab in the treatment of membranous nephropathy A systematic review and meta-analysis
    Lu, WanJun
    Gong, ShuHao
    Li, Juan
    Luo, HongWen
    Wang, Ying
    MEDICINE, 2020, 99 (16) : E19804
  • [26] Ofatumumab in Rituximab-Resistant and RituximabIntolerant Patients With Primary Membranous Nephropathy: A Case Series
    Podesta, Manuel Alfredo
    Trillini, Matias
    Portalupi, Valentina
    Gennarini, Alessia
    Tomatis, Federica
    Villa, Alessandro
    Perna, Annalisa
    Rubis, Nadia
    Remuzzi, Giuseppe
    Ruggenenti, Piero
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2024, 83 (03) : 340 - 349.e1
  • [27] Efficacy of tacrolimus monotherapy in primary membranous nephropathy
    Zhang, Ya-pu
    Ran, Lei
    Guo, Li
    Gou, Yan-Li
    Guo, Shan-shan
    Xu, Yang
    Hua, Xin
    Chen, Hang
    OPEN MEDICINE, 2024, 19 (01):
  • [28] Rituximab in Idiopathic Membranous Nephropathy
    Ruggenenti, Piero
    Cravedi, Paolo
    Chianca, Antonietta
    Perna, Annalisa
    Ruggiero, Barbara
    Gaspari, Flavio
    Rambaldi, Alessandro
    Marasa, Maddalena
    Remuzzi, Giuseppe
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2012, 23 (08): : 1416 - 1425
  • [29] Rituximab or Cyclosporine for Membranous Nephropathy
    Ponticelli, Claudio
    Moroni, Gabriella
    NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (17): : 1688 - 1689
  • [30] Rituximab Exhibits Altered Pharmacokinetics in Patients With Membranous Nephropathy
    Fogueri, Uma
    Cheungapasitporn, Wisit
    Bourne, David
    Fervenza, Fernando C.
    Joy, Melanie S.
    ANNALS OF PHARMACOTHERAPY, 2019, 53 (04) : 357 - 363
12345